Offerings // Alto Neuroscience, Inc.

ANRO offering history

Every offering-related filing in Alto Neuroscience, Inc.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 186 filings back to Nov 22, 2023.

Last executed offering

Jul 14, 2026

424B5 — priced deal (shares or notes)

Last registration (announced)

Apr 10, 2026

S-3 — capacity, not a sale

Executed, last 12 months

424B pricings + 8-K 3.02 sales

Registered, last 12 months

S-1/S-3/F-series registrations

Date	Filing		What it means
Jul 14, 2026	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Apr 20, 2026	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Apr 10, 2026	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Mar 16, 2026	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Dec 10, 2025	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Nov 28, 2025	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Oct 20, 2025	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Jun 3, 2025	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Feb 11, 2025	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Feb 3, 2025	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Jan 16, 2025	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Jul 29, 2024	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Feb 5, 2024	424B4 →	EXECUTED	Final prospectus — offering priced (typical for IPOs and marketed share deals)
Feb 1, 2024	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Jan 29, 2024	S-1/A →	REGISTERED	S-1/A registration — capacity to sell shares, not a sale yet
Jan 29, 2024	S-1/A →	REGISTERED	S-1/A registration — capacity to sell shares, not a sale yet
Jan 12, 2024	S-1 →	REGISTERED	S-1 registration — capacity to sell shares, not a sale yet

ANRO offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full ANRO workspace →

ANRO offering FAQ

When did ANRO last execute an offering?

Per SEC filings, Alto Neuroscience, Inc.'s most recent priced offering document is a 424B5 filed 2026-07-14. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did ANRO last announce or register an offering?

The most recent registration is a S-3 filed 2026-04-10. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.